BLCO

BLCO

USD

Bausch + Lomb Corporation Common Shares

$15.550+0.080 (0.517%)

リアルタイム価格

Healthcare
Medical Instruments & Supplies
カナダ

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$15.470

高値

$15.554

安値

$15.300

出来高

0.81M

企業ファンダメンタルズ

時価総額

5.5B

業種

Medical Instruments & Supplies

Canada

取引統計

平均出来高

0.52M

取引所

NYQ

通貨

USD

52週レンジ

安値 $10.45現在値 $15.550高値 $20.712

関連ニュース

BusinessWire

Bausch + Lomb to Hold Investor Day on Nov. 13

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock

もっと見る
Bausch + Lomb to Hold Investor Day on Nov. 13
Analyst Upgrades

Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17

Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.

もっと見る
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17

HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.

もっと見る
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16

JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.

もっと見る
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.

もっと見る
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16

Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.

Analyst Upgrades

Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19

Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。